The illusive trade-off: Intellectual property rights, innovation systems, and Egypt’s pharmaceutical industry

The Illusive Trade-Off: Intellectual Property Rights, Innovation Systems, and Egypt's Pharmaceutical Industry

Volumn , Issue , 2006, Pages 1-232

  Abdelgafar, Basma I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961246758     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (194)

1. Abdelgafar, Basma, Halla Thorsteinsdottir, Uyen Quach, Peter Singer, and Abdallah S. Daar (2004). ‘The Emergence of Egyptian Biotechnology from Generics.’ Nature Biotechnology 22 (12 Supp 1.).
2. Abdelghaffar, Mohamed (2001). ‘Danger Threatens Pharmaceutical Produc-tion.’ Akhbar Al Yom, 29 Sept., 10.
3. Abbott, Frederick (2002). ‘The Doha Declaration on the TRIPS and Public Health: Lighting a Dark Corner at the WTO.’ Journal of International Economic Law 5(2): 469-505.
4. Act Up Paris (2002). ‘Accelerating Access: Serving Pharmaceutical Companies and Corrupting Health Systems.’ Press Release, 15 May. www.actupp.org/article498.html (accessed 20 May 2002).
5. Aghion, Philippe, Nicholas Bloom, Richard Bludell, Rachel Griffith, and Peter Howitt (2002). ‘Competition and Innovation: An Inverted U Relationship.’ http://post.economics.harvard.edu/faculty/aghion/papers/comp_ and_innov.pdf (accessed 5 Oct. 2002).
6. Aith, Marcio (2000). ‘Patent Laws Can Generate Conflict with U.S.’ Folha de Sao Paulo, 12 Feb. http://www.cptech.org/ip/health/c/brazil (accessed 15 Oct. 2002).
7. Al Ahram (2001). ‘Flying Machines and Electric Toothbrushes.’ Al Ahram Weekly Online, no. 539, 21-7 June.
8. Al Alam Al Yom (1999). ‘After the Minister of Economy Insists on the Grace Period the Debate over Drug Production Intensifies: Intensification of the Debate over the Future of Drug Production.’ Al Alam Al Yom, 27 July, 3.
9. Al Ansari, Mahfouz (1999). ‘Mubarak and Drugs, Egyptian Health, the NATO Alliance and the Copenhagen Alliance.’ Al Ahram, 27 Feb., 13.
10. Al Bassil, Abd Al Azim et al. (2002). ‘Problems Re: Drug Access and Public Health in Egypt - Beyond IP.’ Al Ahram Special Report, 15 June, 20-1.
11. Alden, Edward, Geoff Dyer, Ken Warn, and Bettina Wassener (2001). ‘Manufacture of Antibiotics: Bayer Urged to Cut Price of Drugs to Help America in Its Fight Against Anthrax.’ Financial Times, 24 Oct., 4.
12. Ali El Din. Baha, and Mahmoud Mohieldin (2001). ‘On the Formulation and Enforcement of Competition Law in Emerging Economies: The Case of Egypt.’ Egyptian Center for Economic Studies, Working Paper No. 60.
13. Alt, James E., Randall L. Calvert, and Brian D. Humes (1986). ‘Game Theory and Hegemonic Stability: The Role of Reputation and Uncertainty.’ Political Economy Working Paper 106. St Louis: Washington University, Center for Political Economy.
14. Andersen, Esben Sloth, and Bengt-Ake Lundvall (1988). ‘Small National Sys-tems of Innovation Facing Technological Revolutions: An Analytic Frame-work.’ In Christopher Freeman and Bengt-Ake Lundvall (eds.), Small Countries Facing the Technological Revolution, 9-36. London: Pinter.
15. Arrow, Kenneth (1962). ‘Economic Welfare and the Allocation of Resources for Invention.’ In Universities-National Bureau Committee for Economic Research (ed.), The Rate and Direction of Inventive Activity: Economic and Social Factors. A Conference of the Universities-National Bureau Committee for Economic Research and the Committee on Economic Growth of the Social Science Research Council, 609-25. Princeton, NJ: Princeton University Press.
16. Baba, Yasunori, and Ken-ichi Imai (1992). ‘Systemic Innovation and Cross Border Networks: The Case of the Evolution of the VCR Systems.’ In Frederick M. Scherer and Mark Perlman (eds.), Entrepreneurship, Technological Innovation, and Economic Growth: Studies in the Schumpeterian Tradition, 141-52. Ann Arbor: University of Michigan Press.
17. Banta, David (2000). ‘Increase in Global Access to Essential Drugs Sought.’ Journal of the American Medical Association 283(3), 19 Jan.
18. Bale, Harvey (1988). ‘A Computer and Electronics Industry Perspective.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 119-26. London: University of America Press.
19. Barr, Stephen (1999). ‘Pfizer Defiant - How David Shedlarz Challenges the Analysts.’ CFO: The Magazine for Senior Financial Executives, July, 36-42.
20. Barzel, Yoram (1968). ‘Optimal Timing of Innovations.’ Review of Economics and Statistics, Aug., 348-55.
21. Bayer (2001). ‘Bayer to Supply Government by Year End with 100 Million Tablets for $95 Million.’ Bayer Press Release, Bay News International. www.news.bayer.com/News/News.nsf/id/01-0350. Accessed 24 Oct. 2001.
22. Benko, Robert P. (1987). Protecting Intellectual Property Rights. Washington, DC: American Enterprise Institute for Public Policy Research.
23. Bessen, James, and Eric Maskin (2000). ‘Sequential Innovation, Patents and Imitation.’ Working Paper No. 100-01, Department of Economics, MIT.
24. Bonin, Bernard (1991). ‘Oligopoly, Innovation, and Firm Competitiveness.’ In Jorge Niosi (ed.), Technology and National Competitiveness: Oligopoly, Technological Innovation, and International Competition, 267-81. Montreal: McGill- Queen’s University Press.
25. Brown, Lawrence A. (1981). Innovation Diffusion: A New Perspective. London: Methuen.
26. Chambers, R. (1983). Rural Development: Putting the Last First. London: Longman.
27. Chesnais, François (1991). ‘Technological Competitiveness Considered as a Form of Structural Competitiveness.’ In Jorge Niosi (ed.), Technology and National Competitiveness: Oligopoly, Technological Innovation, and International Competition, 142-76. Montreal: McGill-Queen’s University Press.
28. Chesnais, François (1992). ‘National Systems of Innovation, Foreign Direct Investments and Other Operations of Multinational Enterprises.’ In Bengt-Ake Lundvall (ed.), National Systems of Innovation: Toward a Theory of Innovation and Interac-tive Learning, 265-95. London: Pinter.
29. CIPR (2002). Integrating Intellectual Property Rights and Development Policy: Report of the Commission on Intellectual Property Rights. London: Commission on Intellectual Property Rights. http: //www.iprcommission.org (accessed 20 Sept. 2002).
30. Clemente, C.L. (1988). ‘A Pharmaceutical Industry Perspective.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 127-34. London: University of America Press.
31. Correa, Carlos A. (1995). ‘Intellectual Property Rights and Foreign Direct Investment.’ International Journal of Technology Management. Special Issue on the Management of International Intellectual Property, 10(2/3): 173-99.
32. Correa, Carlos A. (1998). ‘Implementing TRIPS in Developing Countries.’ http:”www.twnside.org.sg/souths/twn/title/ment-cn.htm (accessed 25 April 1998).
33. Correa, Carlos A. (2000). ‘The Strengthening of IPRs in Developing Countries and Comple-mentary Legislation.’ Report prepared upon request of DFID (UK), Oct.
34. Correa, Carlos A. (2001). ‘Some Assumptions on Patent Law and Pharmaceutical R&D.’ Occa-sional Paper No. 6. Geneva: Quaker UN Office.
35. Costa, Mauricio E.C. (1988). ‘A View from Brazil.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 57-64. London: University of America Press.
36. Dasgupta, Partha (1986). ‘The Theory of Technological Competition.’ In Joseph Stiglitz and G. Frank Mathewson (eds.), New Developments in the Analysis of Market Structure, 519-47. Cambridge, MA: MIT Press.
37. Dasgupta, Partha (1988). ‘The Welfare Economics of Knowledge Production.’ Oxford Review of Economic Policy, 4(4): 1-12.
38. Davis, Paul (2002). ‘Re: Urgent: Fast Track Vote against Affordable Meds and PWAs Probable Today.’ Ip-health listserv. http:”lists.essential.org/pipermail/ip-health/2002-July/003330.html (accessed 26 July 2002).
39. de Almeida, Paulo R. (1995). ‘The Political Economy of Intellectual Property Protection: Technological Protectionism and Transfer of Revenue among Nations.’ International Journal of Technology Management, Special Issue on the Management of International Intellectual Property, 10(2/3): 214-29.
40. Deardorff, Allan V. (1992). ‘Welfare Effects of Global Patent Protection.’ Economica, 59: 35-51.
41. de Jonquières, Guy (2001). ‘All Night Haggling in Doha Ends in Agreement.’ Financial Times, 15 Nov., 6.
42. Doern, Bruce G., and Markus Sharaput (2000). Canadian Intellectual Property: The Politics of Innovating Institutions and Interests. Toronto: University of Toronto Press.
43. Dosi, Giovanni (1988). ‘Sources, Procedures, and Microeconomic Effects of Innovation.’ Journal of Economic Literature, 26 (Sept.): 1120-71.
44. Dyer, Geoff, and Adrian Michaels (2001). ‘A Bitter Pill for the Drug Makers.’ FT.com Financial Times, 24 Oct. www.ft.com (accessed 26 Oct. 2001).
45. Eggertson, Thrainn (1990). Economic Behaviour and Institutions. Cambridge: Cambridge University Press.
46. El Essawi, Ibrahim (2000). ‘From Reform to Recession.’ Al Ahram Weekly Online, 27 Apr.-3 May, Issue No. 479. http://www.ahram.org.eg/weekly/2000/479/op2.htm (accessed 22 Oct. 2002).
47. El Sawy, Tayseer M. (1997). TRIPS and the Egyptian Drug Market: Final Report, 1 May. Cairo: National Information Centre for Health and Population.
48. Ernst, Dieter, Lynn K. Mytelka, and Tom Ganiatsos (1998). ‘Technological Capabilities in the Context of Export-led Growth: A Conceptual Frame-work’. In Dieter Ernst, Tom Ganiatsos, and Lynn Mytelks (eds.), Technological Capabilities and Export Success in Asia, 5-45. London: Routledge.
49. Essam El-Din. Galal (2000). ‘The Wrong Prescription.’ Al Ahram Weekly Online, 20-6 Apr., Issue No. 478. www.ahram.org.eg/weekly/2000/478/ec2.htm (accessed 1 Nov. 2002).
50. Evans, Robert (2001). ‘Drug Companies Warn AIDS Research Could Dry Up.’ Reuters Limited, 19 Sept. http:”www.spectrum.ieee.org/news/cache/ReutersOnlineScience/09_19_2001.romta1116-story-bcsciencescienceaids- drugsdc.html (accessed 21 Sept. 2001).
51. Evenson, Richard E. (1990). ‘Survey of Empirical Studies.’ In Wolfgang E. Sie-beck with Robert E. Evenson, William Lesser, and Carlos A. Primo Braga(eds.). Strengthening Protection of Intellectual Property in Developing Countries: A Survey of the Literature,’ 33-46. Washington, DC: World Bank.
52. Fawzy, Nahla (2002). ‘New Law Strengthens Investment Climate.’ Egyptian State Information Service, 29 July. www.sis.gov.eg (accessed 21 Sept. 2002).
53. Fayez, Baha El Din (1997). Implications of WTO Rules for Technology Transfer to the Pharmaceutical Industry in ESCWA Member Countries, with Emphasis on the the Case of the Arab Republic of Egypt. Cairo: National Research Centre.
54. Ferrantino, Michael J. (1993). ‘The Effect of Intellectual Property Rights on International Trade and Investment.’ Weltwirtschaftliches Archiv 129: 300-31.
55. Freeman, Christopher (1987). Technology Policy and Economic Performance: Les-sons from Japan. London: Pinter.
56. Freeman, Christopher, and John Hagedoorn (1992). Globalization of Technology. MERIT Research Memorandum 92-013. Maastricht.
57. Freeman, Christopher, and Carlotta Perez (1988). ‘Structural Crises of Adjust-ment: Business Cycles and Invesment Behaviour.’ In G. Dosi, C. Freeman, R. Nelson, G. Silverberg, and L. Soete (eds.). Technical Change and Economic Theory, 38-66. London: Printer.
58. Freeman, Christopher, and Luc Soete (1997). The Economics of Industrial Innovation. Cambridge, MA: MIT Press.
59. Frischtak, Claudio R. (1989). ‘The Protection of Intellectual Property Rights and Industrial Technology Development in Brazil.’ Industry and Energy Department Working Paper, Industry Series Paper No. 13. Washington, DC: World Bank. 29 Sept.
60. Fuhrmans, Vanessa, and Gautam Naik (2002). ‘In Europe Drug Makers Fight against Mandatory Price Cuts.’ Wall Street Journal Online. http://online.wsj.com/article /011SB1023410062557115600100. html?mod= Pagepercent200n (accessed 5 Oct. 2002).
61. Gadbaw, Michael R., and Timothy Richards (1988). Intellectual Property Rights: Global Consensus, Global Conflict? London: Westview.
62. Galal, Essam E. (1983). ‘National Production of Drugs: Egypt.’ World Development, 11(3) pp. 237-41.
63. Galal, Nourhan (1999). The Egyptian Pharmaceutical Sector. Cairo: Commercial International Brokerage Co.
64. Gallini, Nancy (1992). ‘Patent Policy and Costly Imitation.’ Rand Journal of Economics 23: 52-63.
65. Gilbert, Richard, and Carl Shapiro (1990). ‘Optimal Patent Length and Breadth.’ Rand Journal of Economics 21: 106-12.
66. Grabowski, Henry, and John Vernon (1986). ‘Longer Patents for Lower Imitation Barriers: The 1984 Drug Act.’ R&D, Innovation, and Public Policy 76(2): 195-8.
67. Grossman, Gene, and Elhanan Helpman (1991). Innovation and Growth in the Global Economy. Cambridge, MA: MIT Press.
68. Haagsma, Auke (1988). ‘A View from the European Community.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 65-76. London: University of America Press.
69. Hagedoorn, John, and Jos Schakenraad (1991). ‘The Internationalization of the Economy, Global Strategies and Strategic Technology Alliances.’ Nouvelles de la ssience et des technologies 9(2): 29-41.
70. Harmsen, Richard, and Arvind Subramanian (1994). ‘Economic Implications of the Uruguay Round.’ In Naheed Kirmani (staff team leader), International Trade Policies: The Uruguay Round and Beyond, vol. 2, Background Papers, 1-31. Washington: International Monetary Fund, 1-31.
71. Hassan, Tarek Mohamed Ali (1997). ‘Strategic Planning for the Improvement of Quality in Egyptian Drug Production in the Shadow of the WTO.’ Unpublished MA dissertation, Ain Shams University, Cairo.
72. Hemsley, Devlin J. (1997). ‘Management Views on Industry Issues, Pressures and Consultants.’ Script Magazine, 17 June.
73. Henderson, Rebecca, Luigi Orsenigo, and Gary Pisano (1999). ‘The Pharma-ceutical Industry and the Revolutions in Molecular Biology: Interactions among Scientific, Institutional and Organizational Change.’ In David Mow- ery and Richard Nelson (eds.), Sources of Industrial Leadership: Studies of Seven Industries, 267-311. Cambridge: Cambridge University Press.
74. Hoekman, Bernard (1994). ‘Services and Intellectual Property Rights.’ In Susan M. Collins and Barry Bosworth (eds.), The New GATT: Implications for the United States, 84-122. Washington, DC: Brookings Institution.
75. Hudec, Robert E. (1987). Developing Countries in the GATT Legal System. Sydney: Gower.
76. Hudec, Robert E (1991). Enforcing International Trade Law: The Evolution of the Modern GATT Legal System. Austin: Butterworth.
77. Ibrahim, Mohsen M. (1996). ‘Future of Research in Hypertension in Developing Countries.’ Eastern Mediterranean Health Journal 2(2): 202-5. http://www.emro.who.int/Publications/EMHJ/0202/02.htm (accessed 16 Nov. 2002).
78. ICTSD (2002a). ‘Divisive Debate over TRIPS and Public Health Continues in TRIPS Council.’ Bridges Weekly Trade News Digest 6(9). http://www.ictsd.org/weekly/02-03-12/story2.htm (accessed 20 Mar. 2002).
79. ICTSD (2002b). ‘Access to Medicines in Spotlight at TRIPS Council.’ Bridges Weekly News Digest 6(24). http://www.ictsd.org/weekly/02-06-26/story3.htm (accessed 20 Mar. 2002).
80. Industry Canada (1997). Sector Competitiveness Frameworks: Pharmaceutical Industry, Part 1, Overview Prospects. Ottawa: Industry Sector Health Industries.
81. Jacobzone, S. (2000). ‘Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals.’ Labour Market and Social Policy - Occasional Papers No. 40. Paris: OECD.
82. Jaffe, Adam (2000). ‘The U.S. Patent System in Transition: Policy Innovation and the Innovation Process.’ Research Policy 29: 531-57.
83. Kamath, Gauri (2001). ‘U.S. Bill May Deprive Developing Nations of Cheap Drugs.’ Economic Times, 20 Nov. http://economictimes.indiatimes.com/cms.dll/xml/comp/default? (accessed 20, 2001).
84. Keefauver, William L. (1988). ‘Communications: An Industry Perspective.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 143-50. London: University of America Press.
85. Keohane, Robert (1984). After Hegemony: Cooperation and Discord in the World Political Economy. Princeton: Princeton University Press.
86. Kirim, Arman (1985). ‘Reconsidering Patents and Economic Development: A Case Study of the Turkish Pharmaceutical Industry.’ World Development 13(2): 219-36.
87. Klemperer, Paul (1990). ‘How Broad Should the Scope of Patent Protection Be?’ Rand Journal of Economics 21: 113-30.
88. Lall, Sanjaya (1974). ‘The International Pharmaceutical Industry and Less Developed Countries with Special Reference to India.’ Oxford Bulletin of Economics and Statistics 36(3): 143-72.
89. Leahy, Patrick J. (1988). ‘U.S. Congressional Approaches to Reconciling Intel-lectual Property Rights.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 77-82. London: University of America Press.
90. Lesser, William (1990). ‘An Overview of Intellectual Property Systems.’ In Wolfgang E. Siebeck et al. (eds.), Strengthening Protection of Intellectual Property in Developing Countries, 5-15. Washington, DC: World Bank.
91. Lipsey, Richard (1991). Economic Growth: Science and Technology and Institutional Change in a Global Economy. Toronto: Canadian Institute for Advanced Research.
92. Loury, Glenn C. (1979). ‘Market Structure and Innovation.’ Quarterly Journal of Economics 93(3): 395-410.
93. Love, James (2001). ‘Access to Medicine and Compliance with the WTO TRIPS
94. Accord: Models for State Practice in Developing Countries.’ Paper prepared for the U.N. Development Program, 21 Jan. www.cptech.org/ip/health/cl/recommendedstatepractice.html (accessed 31 Mar. 2001).
95. Love, James (2002). ‘Access to Medicines: Solving the Export Problem under TRIPS.’ Bridges 6(4): 3. http://www.cptech.org/ip/wto/bridges-exports.html (accessed 5 June 2002).
96. Love, James (2003a). ‘CPTech Statement on WTO Deal on Exports of Medicines - August 30, 2003.’ Patent Exception for Exports to Address Health Needs - Letters, State-ments and Press Releases. http://www.cptech.org/ip/wto/p6/(accessed 5 Jan. 2005).
97. Love, James (2003b). ‘TRIPS Council to Meet on August 28, at 4:30.’ IP-Health List Serve. http: //lists.essential.org/pipermail/ip-health/2003-August/005171.html (accessed 5 Jan. 2005).
98. Lundvall, Bengt-Ake (1992). ‘Introduction.’ In Bengt-Ake Lundvall (ed.), National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, 1-22. London: Pinter.
99. Mabry, Marcus (1999). ‘Give Us This Day Our Daily Meds.’ Newsweek Interna-tional 134(1): 22-5.
100. Macan-Markar, Marwan (2001). ‘Trade: Asian Governments Want Clear WTO Agenda.’ IPS, 28 Sept.
101. Malecki, Edward J. (1997). Technology and Economic Development: The Dynamics of Local, Regional and National Competitiveness. Edinburgh: Longman.
102. Mansfield, Edwin (1988). ‘Intellectual Property Rights, Technological Change, and Economic Growth.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 3-26. London: University of America Press.
103. Mansfield, Edwin, John Rapoport, Jerome Schnee, Sam Wagner, and Michael Hamburger (1971). Research and Innovation in the Modern Corporation. New York: Norton.
104. Maskus, Keith (1998). ‘The Role of Intellectual Property Rights in Encouraging Foreign Direct Investment and Technology Transfer.’ Duke Journal of Comparative International Law. 9(1): 109.
105. Maskus, Keith, and Mohan Penubarti (1995). ‘How Trade-Related Are Intellec-tual Property Rights?’ Journal of International Economics 39: 227-48.
106. Mc Donagh, Patrick (2001). ‘Taking McGill to Market.’ McGill News Alumni Quarterly 80(4). http://www.mcgill.ca/news/archives/winter2000/market/(accessed 10 May 2001).
107. McKelvey, Maureen (1991). ‘How Do National Systems of Innovation Differ? A Critical Analysis of Porter, Freemen, Lundvall and Nelson.’ In Geoffrey Hodgson and Ernesto Screpanti (eds.), Rethinking Economics: Markets, Technology and Economic Evolution, 117-37. Aldershot: Edward Elgar.
108. Michaels, Adrian (2001). ‘The Race for a Drug Is a Close One.’ Financial Times, 2 Sept., 12.
109. Ministry of Economy. (1998). A New Business Environment for a Great Country. Qalyoub: Al Ahram Commercial Press.
110. Ministry of Economy. (2000). Egypt 2000. Cairo: Ministry of Economy.
111. Ministry of Scientific Research (MOSR) (1997). ‘Final Overview Report for Project on Improving the Science and Technology Policy and Management in Egypt: A World Bank-IDF Funded Project, WB28836.’ Cairo.
112. Mohieldin, Mahmoud. (2002). ‘A Stitch in Time.’ Al Ahram Weekly Online, 21-7 Mar., issue no. 578.
113. Moreau, Ron (1999). ‘Thailand Plays by the Rules.’ Newsweek International, 5 Jul., 24.
114. Mostafa, Hadia (2004). ‘Overdose?’ Business Today Egypt, www.businesstodayegypt.com/arttemplate.asp?ArtID=2&IssueNo=05& IssueNo=05&IssueYear=04&MagID=BT (accessed 12 May 2004).
115. Mowery, David and Nathan Rosenberg (1989). Technology and the Pursuit of Economic Growth. Cambridge: Cambridge University Press.
116. MSF, Oxfam, TWN (2001). ‘Re: TRIPS Council Special Discussion on Access to Medicines, September 19, 2001.’ Ip-health listserv. http://lists.essential.org/pipermail/ip-health/2001-September/001874.html (accessed 20 Sept. 2001).
117. Mytelka, Lynn K. (1998). ‘Competition, Innovation, and Competitiveness: Learning to Innovate under Conditions of Dynamic Industrial Change.’ Paper prepared for the International Conference: The Economics of Indus-trial Structure and Innovation Dynamics, Centro Cultural de Belem, Lisbon, 16-17 Oct.
118. Mytelka, Lynn K. (1999). Competition, Innovation and Competitiveness in Developing Countries. Paris: OECD.
119. Namfua, Macel W., and Abdulqawi A. Yusuf (1991). Africa and the TRIPS Negotiations in the Uruguay Round. UNCTAD/UNDP Project RAF/87/157.
120. Nelson, Richard (1993). National Innovation Systems: A Comparative Analysis. New York: Oxford University Press.
121. Nelson, Richard (1996). The Sources of Economic Growth. Cambridge: Harvard University Press.
122. Nelson, Richard, and Nathan Rosenberg (1993). ‘Technical Innovation and National Systems.’ In Richard Nelson (ed.), National Innovation Systems: A Comparative Analysis, 3-28. New York: Oxford University Press.
123. New York Times. (2002). ‘A Fairer Trade Bill.’ New York Times on the Web, 25 Jul., www.nytimes.com /2002/07/25/opinion/25THU3.html?pagewanted= print&position=bottom (accessed 28 July 2002).
124. Nogues, Julio (1990). ‘Patents and Pharmaceutical Drugs: Understanding the Pressures on Developing Countries.’ Journal of World Trade 24(6): 81-104.
125. Nogues, Julio (1993). ‘Social Costs and Benefits of Introducing Patent Protection for Phar-maceutical Drugs in Developing Countries.’ The Developing Economies 31(1): 24-53.
126. Nordhaus, William S. (1969). Invention, Growth and Welfare: A Theoretical Treat-ment of Technological Change. Cambridge, MA: MIT Press.
127. OECD (1971). The Conditions for Success in Technological Innovation. Paris
128. OECD (1992), Technology and the Economy: The Key Relationships. Paris: OECD.
129. Orabi, Mahitab, and Mohamed Nour El Din (1999). Egypt: Pharmaceutical Sector Review. Cairo: EFG-Hermes.
130. Ostry, Sylvia (1990), Governments and Corporations in a Shrinking World: Trade and Innovation Policies in the United States, Europe and Japan. New York: Council on Foreign Relations Press.
131. Ostry, Sylvia, and Richard Nelson (1995). Techno-Nationalism and Techno-Globalism: Conflict and Cooperation. Washington, DC: Brookings Institution.
132. Oxfam, (2001). ‘Fatal Side Effects: Medicine Patents under the Microscope.’ Oxfam GB Policy Paper, Feb. www.oxfam.org.uk/cutthecost/downloads/policy3.rtf (accessed 10 July 2001).
133. Oxfam (2002). ‘U.S. Bullying on Drug Patents: One Year After Doha.’ Oxfam Brief-ing Paper, No. 33, Nov. http://www.oxfam.org.uk/policy/papers/33bullying/33bullying.pdf (accessed 16 Nov. 2002).
134. Pack, Howard, and Larry Westphal (1986). ‘Industrial Strategy and Technological Change: Theory Versus Reality.’ Journal of Development Economics 22: 87128.
135. Pavitt, K., and P. Patel (1988). ‘The International Distribution and Determinants of Technological Activities.’ Oxford Review of Economic Policy 4(4): 35-55.
136. Pearl, Daniel (1996). ‘No Quick Cure, Big Drug Makers Push Egypt, Other Nations to End Their ‘Piracy.”’ Wall Street Journal, 17 Dec., 1 and 12.
137. Perez, Carlota (1988). ‘New Technologies and Development.’ In Christopher Freeman and Bengt-Ake Lundvall (eds.), Small Countries Facing the Technological Revolution, 85-97. London: Pinter.
138. Pharmaceutical Research and Manufacturers of America (PhRMA) (2000). ‘Submission of PhRMA for the ‘Special 301” Report on Intellectual Property Barriers,’ 18 Feb. http://www.phrma.org/policy /aroundworld/special301 (accessed 25 Feb. 2000).
139. Pollard, Stephen (2001). ‘Business Europe: Big Pharmaceuticals take the Gloves Off.’ Wall Street Journal Europe, 17 Dec.
140. Porter, Michael (1990). The Competitive Advantage of Nations. New York: Free Press.
141. Primo Braga, Carlos A. (1990). ‘Guidance from Economic Theory.’ In Wolfgang E. Siebeck et al. (eds.), Strengthening Protection of Intellectual Property in Developing Countries, 17-32. Washington: World Bank.
142. Primo Braga, Carlos A (1991). ‘The North-South Debate on Intellectual Property Rights.’ In Murray G. Smith (ed.), Global Rivalry and Intellectual Property: Developing Canadian Strategies, 173-82. Halifax: Institute for Research on Public Policy.
143. Primo Braga, Carlos A., and Carsten Fink (1997). ‘The Economic Justification of the Grant of Intellectual Property Rights: Patterns of Convergence and Conflict.’ In Frederick Abbott and David J. Gerber (eds.), Public Policy and Global Technological Integration, 99-122. London: Kluwer Law International.
144. Primo Braga, Carlos A., and Carsten Fink (2000). ‘International Transactions in Intellectual Property and Developing Countries.’ International Journal of Technology Management 19(1/2): 35-56.
145. Primo Braga, Carlos A., Carsten Fink, and Claudia Paz Sepulveda. (1998). ‘Intellectual Property Rights and Economic Development: Background Paper to the World Development Report 1998.’ http://www.vita.org/technet/iprs/ipr-dcom.htm (accessed 1 May 1998).
146. Pruzin, Daniel (2001). ‘WTO Talks on TRIPS, Public Health Declaration Stalls over Compromise Text.’ International Trade Daily, 24 Oct. http://www.bna.com/products/corplaw/tdln.htm (accessed 25 Oct. 2001).
147. Rath, Amitar (1990). ‘Science, Technology, and Policy in the Periphery: A Per-spective from the Centre.’ World Development 18(11): 1429-43.
148. Richards, Timothy (1988). ‘Intellectual Property Rights: Reconciling Divergent Views.’ In Charles E. Walker and Mark A. Bloomfield (eds.), Intellectual Property Rights and Capital Formation in the Next Decade, 93-8. London: University of America Press.
149. Rifkin, Jeremy (1998). The Biotech Century. New York: Penguin Putnam.
150. Rodrik, Dani (1999). ‘The New Global Economy and Developing Countries: Making Openness Work.’ Policy Essay No. 24. Washington, DC: Overseas Development Council.
151. Romer, Paul (1994). ‘Two Strategies of Economic Development: Using Ideas and Producing Ideas.’ Proceedings of the World Bank Annual Conference on Development Economics. New York: Word Bank, 63-91.
152. Rosegger, Gerhard (1986). The Economics of Production and Innovation: An Indus-trial Perspective. New York: Pergamon Press.
153. Rosenberg, Nathan (1976). Perspectives on Technology. Cambridge: Cambridge University Press.
154. Rozek, Richard, and Ruth Berkowitz (1998). The Effects of Patent Protection on the Prices of Pharmaceutical Products: Is Intellectual Property Protection Raising the Drug Bill in Developing Countries? Washington, DC: National Economic Research Associates.
155. Sabater, Luisa (1995). ‘Multilateral Debt of Least Developed Countries.’ UNCTAD Discussion Paper No. 107. Geneva: UNCTAD.
156. Salama, Adel Mohsen (1997). ‘The Game of the Giants in Drug Manufacture.’ Al Ahram, March.
157. Saxenian, Helen (1994). ‘Getting the Most out of Pharmaceutical Expenditures.’ Human Resources Development and Operations Policy Working Paper No. 37, Sept. www.worldbank.org/html/extdr/hnp/hddflash/hewp/hrwp033.html (accessed 10 Mar. 1999).
158. Scherer, F.M. (1977). The Economic Effects of Compulsory Patent Licensing. New York: New York University Press.
159. Schumpeter, Joseph (1934). The Theory of Economic Development. Cambridge: Harvard University Press.
160. Schumpeter, Joseph (1942). Capitalism, Socialism and Democracy. New York: Harper.
161. Scotchmer, Suzanne, and Jerry Green (1990). ‘Novelty and Disclosure in Patent Law.’ Rand Journal of Economics 21 (1, Spring): 131-46.
162. Segal, Aaron (1987). Learning by Doing: Science and Technology in the Developing World. Boulder, CO: Westview.
163. Sell, Susan (1998). Power and Ideas: North-South Politics of Intellectual Property and Anti-trust. New York: State University of New York Press.
164. Shahidullah, Shahid M. (1991). Capacity Building in Science and Technology in the Third World. Boulder: Westview.
165. Sherwood, Robert M. (1996). ‘The TRIPS: Implications for Developing Countries.’ Study on the Financial and Other Implications of the Implementation of the TRIPS for Developing Countries, commissioned by the World Intellectual Property Organization, Sept.
166. Singh, Ajit (1995). ‘How Did East-Asia Grow So Fast? Slow Progress toward an Analytical Consensus.’ UNCTAD Discussion Paper No. 97. Geneva: UNCTAD.
167. Singh, Ajit, and Rahul Dhumale (1999). ‘Competition Policy, Development and Developing Countries.’ Trade-Related Agenda, Development and Equity Working Paper No. 7, Nov. Geneva: South Centre.
168. Stalson, Helena (1987). Intellectual Property Rights and U.S. Competitiveness in Trade. Washington, DC: National Planning Association.
169. Stiglitz, Joseph (1986). ‘Theory of Competition, Incentives and Risk.’ In Joseph Stiglitz and G. Frank Mathewson (eds.), New Developments in the Analysis of Market Structure, 399-446. Cambridge, MA: MIT Press.
170. Stiglitz, Joseph (2002). ‘Globalism’s Discontents.’ American Prospect, 14 Jan. www.globalpolicy.org/globaliz/econ/2002/0114stiglitz.htm (accessed 10 Feb. 2002).
171. Stoneman, Paul (1987). The Economic Analysis of Technology Policy. Oxford: Clarendon.
172. Stoneman, Paul, and J. Vickers (1988). ‘The Assessment: The Economics of Technology Policy.’ Oxford Review of Economic Policy 4(4): i-xvi.
173. Story, Alan (2000). ‘The Oxfam ‘Access to Essential Medicines” Project: Some Patent and Research and Development Issues.’ Report prepared for Oxfam International. London: Oxfam International.
174. Subramanian, Arvind (1995). ‘Putting Some Numbers on the TRIPS Pharma-ceutical Debate.’ International Journal of Technology Management, Special Issue on the Management of International Intellectual Property 10(2/3): 252-68.
175. Subramanian, Arvind, and Mostafa Abdel-Latif (1997), ‘The Egypt-EU Partner-ship Agreement and the Egyptian Pharmaceutical Sector.’ Working Paper No. 11, Mar. Cairo: Egyptian Center for Economic Studies.
176. Sykes, Allan O. (1992). ‘Constructive Unilateral Threats in International Rela-tions: The Limited Case for Section 301.’ Law and Policy in International Business 23(2): 263-330.
177. Taylor, Christopher T., and Aubrey Silberston (1973). The Economic Impact of the Patent System: A Study of the British Experience. Cambridge: Cambridge University Press.
178. Toft, A. (1990). ‘The New Roles and Facilities of the World Bank.’ IDS Bulletin 21(2): 38-41.
179. United Nations Conference on Trade and Development (UNCTAD) (1997). The TRIPS and Developing Countries. New York: United Nations.
180. Toft, A. (1999), Investment Policy Review: Egypt. Geneva: United Nations.
181. Toft, A. (2001). Competition Policy and the Exercise of Intellectual Property Rights: Revised Report by the UNCTAD Secretariat. Geneva: UN.
182. United Nations Development Programme (UNDP) (1999). Human Development Report. New York: Oxford University Press.
183. United Nations Development Programme (UNDP) (2001). Human Development Report 2001: Making New Technologies Work for Human Development. Oxford: Oxford University Press.
184. United Nations Development Programme (UNDP) (2003). The Arab Human Development Report. New York: United Nations Development Programme, Regional Bureau for Arab States.
185. United States Trade Representative (USTR) (2000). U.S. Trade Representative Special 301 Report for 2000. U.S. Department of State’s Bureau of Interna-tional Information Programs. Washington, DC. http://usinfo.state.gov/ei/Archive/2003/Dec/31-708465.html (accessed 1 Mar. 2006).
186. United Nations Development Programme (UNDP) (2002). ‘Special 301 Country Reports - Priority Watch List.’ USTR/Sectors Intellectual Property. www.ustr.gov/reports/2002/special301-pwl.htm#egypt (accessed 13 Oct. 2002).
187. von. Wartensleben, Aurelie (1983). ‘Major Issues Concerning Pharmaceutical Policies in the Third World.’ World Development 11(3): 169-75.
188. Waldmeir, Patti (2001). ‘Patents and Panics.’ Financial Times, 1 Nov., 14.
189. Williamson, John (1994). The Political Economy of Policy Reform. Washington, DC: Institute for International Economics.
190. World Bank (1992). ‘World Bank Support for Industrialization in Korea, India, and Indonesia.’ A World Bank Operations Evaluation Study. Washington, DC: OED World Bank.
191. World Bank (2001). Global Economic Prospects and the Developing Countries 2002: Making Trade Work for the World’s Poor. New York: World Bank.
192. Yerkey, Gary G., and Daniel Pruzin (2001a). ‘United States Drops WTO Case against Brazil over HIV/AIDS Patent Law.’ Washington, DC: Bureau of National Affairs Inc., 26 June. http://www.cptech.org/ip/health/c/brazil/bna06262001.html (accessed 2 Nov. 2002).
193. Yerkey, Gary G., and Daniel Pruzin (2001b). ‘WTO Provisional Agreement on TRIPS Reached at WTO Ministe-rial in Doha.’ International Trade Reporter. http://www.bna.com/itrnews/story7.htm (accessed 5 Nov. 2002).
194. Zein El Abedien, Ghada (2001). ‘TRIPS for Drugs - Between Patents and Monopoly.’ Akhbar Al Yom, 11 June, 3.